Quest Diagnostics Inc (DGX) SEC Filing 8-K Material Event for the period ending Monday, March 4, 2019

Quest Diagnostics Inc

CIK: 1022079 Ticker: DGX

View differences made from one to another to evaluate Quest Diagnostics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Quest Diagnostics Inc.


Assess how Quest Diagnostics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Quest Diagnostics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: DGX
CIK: 1022079
Form Type: 8-K Corporate News
Accession Number: 0000947871-19-000180
Submitted to the SEC: Mon Mar 04 2019 5:15:17 PM EST
Accepted by the SEC: Mon Mar 04 2019
Period: Monday, March 4, 2019
Industry: Medical Laboratories
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: